Federal award (BPA CALL, fiscal year 2024)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-10-01 to 2024-09-30
Current total value of award: $718135.28
Description: RADIOACTIVE DRUG INDICATED FOR POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITIVE LESIONS IN MEN WITH PROSTATE CANCER WITH SUSPECTED METASTASIS